ID
24753
Descrizione
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive
Keywords
versioni (3)
- 16-08-17 16-08-17 -
- 16-08-17 16-08-17 -
- 16-08-17 16-08-17 -
Caricato su
16 augustus 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
daily record card administration salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
daily record card administration salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
Descrizione
Next Clinic Visit
Alias
- UMLS CUI-1
- C0008952
Similar models
daily record card administration salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
C0920316 (UMLS CUI [1,2])
C1442065 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
Non ci sono commenti